Related references
Note: Only part of the references are listed.Carrier frequency of SMN1-related spinal muscular atrophy in north Indian population: The need for population based screening program
Mayank Nilay et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)
Newborn Screening for Spinal Muscular Atrophy: Ontario Testing and Follow-up Recommendations
Hugh J. McMillan et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2021)
Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go
Tamara Dangouloff et al.
NEUROMUSCULAR DISORDERS (2021)
Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years
Katharina Vill et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010
J. Gerard Loeber et al.
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2021)
High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR
Ludwig Czibere et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
The implementation of newborn screening for spinal muscular atrophy: the Australian experience
Didu S. T. Kariyawasam et al.
GENETICS IN MEDICINE (2020)
Twenty-Five Years of Spinal Muscular Atrophy Research: From Phenotype to Genotype to Therapy, and What Comes Next
Brunhilde Wirth et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 21, 2020 (2020)
Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy
Debra Stevens et al.
ANNALS OF PHARMACOTHERAPY (2020)
Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy
Denise M. Kay et al.
GENETICS IN MEDICINE (2020)
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey?
Maria Carmela Pera et al.
PLOS ONE (2020)
The Human Gene Mutation Database (HGMD(R)): optimizing its use in a clinical diagnostic or research setting
Peter D. Stenson et al.
HUMAN GENETICS (2020)
New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges
Sonia Messina et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy in 13,069 Chinese Pregnant Women
Jingjing Zhang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Impact of a national population-based carrier-screening program on spinal muscular atrophy births
Sharon Aharoni et al.
NEUROMUSCULAR DISORDERS (2020)
Intragenic variants in the SMN1 gene determine the clinical phenotype in 5q spinal muscular atrophy
Rodrigo de Holanda Mendonca et al.
NEUROLOGY-GENETICS (2020)
Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?
Wolfgang Mueller-Felber et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2020)
Evaluation of Genotypes and Epidemiology of Spinal Muscular Atrophy in Greece: A Nationwide Study Spanning 24 Years
Kyriaki Kekou et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2020)
Assessment of Spinal Muscular Atrophy Carrier Status by Determining SMN1 Copy Number Using Dried Blood Spots
Yogik Onky Silvana Wijaya et al.
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2020)
Newborn screening for SMA in Southern Belgium
Francois Boemer et al.
NEUROMUSCULAR DISORDERS (2019)
Onasemnogene Abeparvovec: First Global Approval
Sheridan M. Hoy
DRUGS (2019)
De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany
Kirsten Koenig et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
Darryl C. De Vivo et al.
NEUROMUSCULAR DISORDERS (2019)
Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives
Tamara Dangouloff et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2019)
A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study
Masakazu Shinohara et al.
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2019)
One Year of Newborn Screening for SMA - Results of a German Pilot Project
Katharina Vill et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2019)
Pilot study of population-based newborn screening for spinal muscular atrophy in New York state
Jennifer N. Kraszewski et al.
GENETICS IN MEDICINE (2018)
Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics
Richard S. Finkel et al.
NEUROMUSCULAR DISORDERS (2018)
Correlation between SMA type and SMN2 copy number revisited: An analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases
Maite Calucho et al.
NEUROMUSCULAR DISORDERS (2018)
Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
Eugenio Mercuri et al.
NEUROMUSCULAR DISORDERS (2018)
Large gene panel sequencing in clinical diagnosticsresults from 501 consecutive cases
S. Pajusalu et al.
CLINICAL GENETICS (2018)
Effectiveness of whole exome sequencing in unsolved patients with a clinical suspicion of a mitochondrial disorder in Estonia
Sanna Puusepp et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2018)
A multi-source approach to determine SMA incidence and research ready population
Ingrid E. C. Verhaart et al.
JOURNAL OF NEUROLOGY (2017)
Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening
Yin-Hsiu Chien et al.
JOURNAL OF PEDIATRICS (2017)
Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy a literature review
Ingrid E. C. Verhaart et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7-9 November 2014, Heemskerk, The Netherlands
Richard Finkel et al.
NEUROMUSCULAR DISORDERS (2015)
Delay in Diagnosis of Spinal Muscular Atrophy: A Systematic Literature Review
Chia-Wei Lin et al.
PEDIATRIC NEUROLOGY (2015)
Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of > 72 400 specimens
Elaine A. Sugarman et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
Newborn and Carrier Screening for Spinal Muscular Atrophy
Thomas W. Prior et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
The c.859G > C variant in the SMN2 gene is associated with types II and III SMA and originates from a common ancestor
S. Bernal et al.
JOURNAL OF MEDICAL GENETICS (2010)
Incidence of Spinal Muscular Atrophy in Poland - More Frequent than Predicted?
Maria Jedrzejowska et al.
NEUROEPIDEMIOLOGY (2010)
A population-based study of genotypic and phenotypic variability in children with spinal muscular atrophy
Eva Arkblad et al.
ACTA PAEDIATRICA (2009)
A Positive Modifier of Spinal Muscular Atrophy in the SMN2 Gene
Thomas W. Prior et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene
Laura Alias et al.
HUMAN GENETICS (2009)
Unaffected patients with a homozygous absence of the SMN1 gene
Maria Jedrzejowska et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
Descriptive epidemiology of spinal muscular atrophy type I in Estonia
Eve Vaidla et al.
NEUROEPIDEMIOLOGY (2006)
Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2
TW Prior et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2
MD Mailman et al.
GENETICS IN MEDICINE (2002)
Share Paper
